Abstract: The present disclosure relates to extending workload provisioning using a low-code development platform. Some embodiments include a medium having instructions to provide an interface for creating a custom resource in a virtualized environment, the interface including a first portion configured to receive summary information corresponding to the custom resource, and a second portion configured to receive a schema corresponding to the custom resource. Some embodiments include creating the custom resource according to the summary information and the schema.

Abstract: The present invention relates to an N-terminal fragment of an angiopoietin like 4 (ANGPTL4) polypeptide, or a therapeutically active variant thereof, for use in the treatment of cancer in a subject. Moreover, the present invention provides an agent which increases the amount of an N-terminal fragment of an angiopoietin like 4 (ANGPTL4) polypeptide for use in treating cancer. Further, encompassed by the present invention is a method for identifying a candidate compound for the treatment of cancer.